NCT05214781

Brief Summary

Breast cancer is a major cause of mortality among women if not treated in early stages. Early screening and diagnosis have a lot to do with the therapeutic effect of prognosis . Nodal status in breast cancer is one of the determining factors for staging, treatment, and prognosis. Nodal status in breast cancer is one of the determining factors for staging, treatment, and prognosis. Nodal status in breast cancer is one of the determining factors for staging, treatment, and prognosis . Intramammary lymph nodes (IMLN) are defined as a lymph nodes that should be surrounded by breast tissue in all sides, which differentiate them from those in the axillary region . Normal IMLN are typically described in all imaging study (mammography, ultrasound and magnetic resonance imaging \[MRI\]) as a circumscribed mass, smaller than 10 mm, with oval shape and hilar fat, usually at a peripheral location, adjacent to a vein . The most common location (about 70%) is the upper outer quadrants, however, it may be located anywhere in the breast .

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 14, 2021

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

January 4, 2022

Completed
27 days until next milestone

First Posted

Study publicly available on registry

January 31, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 4, 2022

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 4, 2023

Completed
Last Updated

February 14, 2022

Status Verified

January 1, 2022

Enrollment Period

11 months

First QC Date

January 4, 2022

Last Update Submit

January 29, 2022

Conditions

Keywords

breast surgery , breast cancer , magnetic resonance image

Outcome Measures

Primary Outcomes (1)

  • prediction of axillary lymph nodes status

    prediction of axillary lymph nodes status by detection of Intramammary lymph nodes by radiological study.

    6 months

Secondary Outcomes (1)

  • pathological correlation

    7 months

Interventions

excision of the whole breast tissue including nipple and skin with axillary clearance

Also known as: conservative breast surgey

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

This is a prospective study, which will be conducted at Mansoura University Hospital from September 2021 till September 2023. This study will include thirty patients with breast cancer, after informed written consent taken from each case before being included in the study.

You may qualify if:

  • Female patients aged more than 18 years old presented with breast cancer with radiologically detected intramammary lymph nodes and agreed to participate in the study

You may not qualify if:

  • Pregnancy.
  • Psychological instability.
  • Patients who refused to participate in our study.
  • Patients whose age less than 18 years old.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

faculty of medicine-Mansoura university - Egypt

Al Mansurah, 35111, Egypt

Location

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Mastectomy, Modified Radical

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Mastectomy, RadicalMastectomySurgical Procedures, Operative

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant lecturer of general surgery

Study Record Dates

First Submitted

January 4, 2022

First Posted

January 31, 2022

Study Start

September 14, 2021

Primary Completion

August 4, 2022

Study Completion

March 4, 2023

Last Updated

February 14, 2022

Record last verified: 2022-01

Locations